Completed
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
NCT00000626
- Conditions
- AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
- Locations
-
- Alabama Therapeutics CRS Birmingham, Alabama, United States
- USC CRS Los Angeles, California, United States
- Northwestern University CRS Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States